Invesco’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Invesco’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-208,179	Closed	-$4.36M	–	3768
2016 Q3	$4.36M	Buy	+208,179	New	+$2.4M	﹤0.01%	2073
2016 Q2	–	Sell	-46,421	Closed	-$308K	–	3767
2016 Q1	$308K	Sell	46,421 -62,340	-57%	-$567K	﹤0.01%	3433
2015 Q4	$1.97M	Sell	108,761 -836	-0.8%	-$11.5K	﹤0.01%	2536
2015 Q3	$1.21M	Buy	109,597 +109,263	+32,713%	+$1.16M	﹤0.01%	2814
2015 Q2	$5K	Buy	+334	New	+$4.54K	﹤0.01%	4260

Invesco's VTAE Position: Q4 2016 in Review

Invesco sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 208,179 shares — an estimated $4.36M sold.

Invesco first reported a position in VTAE in Q2 2015 and held it in 5 quarters. The position peaked at $4.36M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Invesco reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Invesco sold 208,179 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $4.36M.
Invesco first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2015 and held it in 5 quarters.
Invesco's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $4.36M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Invesco's 13F filing for Q4 2016, filed 14 Feb 2017.